Last reviewed · How we verify
NCT04426565
The Follow-up Study for the Patients of Illicit Substance Use Disorder
NA trial testing motivational enhancement interview in Substance Use Disorders in 500 participants. Status unknown.
30 December 2021
Quick facts
| Lead sponsor | Kaohsiung Kai-Suan Psychiatric Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 500 |
| Start date | 1 May 2020 |
| Primary completion | 30 December 2021 |
| Estimated completion | 30 September 2022 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- motivational enhancement interview
- the individual psychotherapy
- the group psychotherapy
- the family therapy
Conditions studied
- Substance Use Disorders — all drugs for Substance Use Disorders →
- Illicit Drug Use — all drugs for Illicit Drug Use →
Sponsor
Kaohsiung Kai-Suan Psychiatric Hospital
Who can join
Adults 20 to 65, any sex, with Substance Use Disorders or Illicit Drug Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The patients will be diagnosed according to DSM-5, the severity of individual substance use disorder will be assessed, and the plan of treatment will be provided. The treatment will be determined by the diagnosis and severity of addiction, the mood or psychiatric comorbidities, the hyperactivity or attention deficit, alcohol addiction, and etc. The motivational enhancement interview, the individual psychotherapy, the group psychotherapy, the family therapy will be provided by our team members. In order to evaluate the efficacy of the different therapy, we will evaluate the psychological and social status of the patients and follow up every 3 months. The efficacy of different treatment will be evaluated according to our study instruments.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04426565
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Substance Use Disorders
Currently open trials in the same condition.
- NCT07219394 — Peer-Delivered Behavioral Activation in a CCBHC · NA · recruiting
- NCT07529327 — Prevent Language Delays and Disorders Among Children of Caregivers With Substance Use Disorders With Community Groups an · NA · recruiting
- NCT07281261 — tAN for Substance Use Disorder · NA · recruiting
- NCT07210268 — Temporal Interference Methods for Addiction Treatment · NA · recruiting
- NCT07146633 — Efficacy of an EMDR App for PTSD and SUD · NA · recruiting
Other Kaohsiung Kai-Suan Psychiatric Hospital trials
Trials by the same sponsor.
- NCT04389476 — The Impact and Coping Strategy of COVID-19 Among Taiwan Society and Medical and Nursing Institutes · unknown
- NCT04093960 — Escitalopram Plus PS128 vs. Escitalopram · Phase 4 · terminated
- NCT04181567 — Comparison of the Efficacy, Safety, and Relapse of ECT to ECT Plus Agomelatine for Depressed Patients · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04426565 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kaohsiung Kai-Suan Psychiatric Hospital
- Last refreshed: 11 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04426565.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing